pain models for neuropathic, nociceptive, inflammatory and post-operative pain

Newsletter

Target NeuroInflammation:
A prectical applications newsletter for inflammations and neurology research.

Register


More Information

Post-operative (Incisional) Pain | Preclinical Contract Research

The under treatment of post-operative (incisional) pain has been recognized to delay patient recovery and discharge from hospital. Despite recognition of the importance of effective pain control, up to 70% of patients still complain of moderate to severe pain post operatively. The most commonly used model to test the effect of new analgesic drugs in post-operative (incisional) pain is the Brennan model in rats. Although, this model can provide good answers to systemic drugs it is less suitable for testing local treatments such as implants, patches, medical devices and creams.

MD Biosciences has developed a unique post-operative (incisional) model in pigs to meet this growing need and allows for the assessment of local and systemic therapies. Models of Post operative (incisional) pain are appropriate for evaluating implants, patches, medical devices and creams and the following drug classes:

  • Cannabinoid Receptor Agonists
  • FAAH Inhibition
  • apha2-adrenergic agonists
  • tricylic anti-depressants
  • NSAIDs
  • opioids
  • TRPV1
  • Sodium Channel Blockers

Post Operative (Incisional) Pain Preclinical Research Models    Request Proposal
Model Post-operative Pain (Brennan)
Post-operative Pain*
Strain

SD rats

Domestic piglets
Length 3-6 days up to 16 days
Positive Control Morphine Morphine
Measurements Body weight
Clinical signs
Mechanical Allodynia
Body weight
Clinical signs
Mechanical Allodynia
Add-ons Blood samples Blood samples, histology

*Whitepaper: A new animal model of post-operative pain. An optimal model for assesssment of analgesic effect of various local treatment strategies such as new implants, patches, medical devices and creams.

Interesting Fact

According to an NIH statistics survey, the four most common types of pain are low back pain (27%), severe headache or migraine pain (15%), neck pain (15%), and facial pain (4%).

Client Testimonial

“Among all the CROs that I have used over the years, including recently for inflammation, MD Biosciences has been one of the very best in terms of scientific knowledge, expertise, data quality, timelines, flexibility and personal contacts.”

O.B., Director of Preclinical Research Pharmaceutical Company